News Conference News THT 2026 Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out Todd Neale March 06, 2026
News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data Todd Neale March 05, 2026
News Conference News THT 2026 Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought Todd Neale March 04, 2026
News Conference News THT 2026 NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER Todd Neale March 04, 2026
News Conference News THT 2026 AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight Todd Neale March 03, 2026
News Conference News THT 2025 Positive Results With Carillon Mitral Device Seen in Real-world Registries Todd Neale February 21, 2025
News Conference News THT 2025 HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt Todd Neale February 18, 2025
News Conference News THT 2025 AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF Todd Neale February 13, 2025
Presentation THT 2025 Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes: An Analysis of the Society Of Thoracic Surgeons National Intermacs Database Presenter: Manreet Kanwar February 13, 2025
News Conference News THT 2025 Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity Todd Neale February 12, 2025
Presentation THT 2025 Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial Presenter: Nir Uriel February 12, 2025
Presentation THT 2025 Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy Presenter: Kanika Mody February 12, 2025
Presentation THT 2025 HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis Presenter: Stavros Drakos February 12, 2025
Presentation THT 2025 The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF Presenter: Kanika Mody February 12, 2025
Presentation THT 2025 Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis Presenter: Stavros Drakos February 12, 2025
Presentation THT 2025 Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group Presenter: Kevin John February 12, 2025
Presentation THT 2025 DOACS in LVAD: Should We, Should We Not? Presenter: Palak Shah February 12, 2025
Presentation THT 2025 Eliminating the Driveline: The Ultimate Solution Presenter: Melana Yuzefpolskaya February 12, 2025